Clinical Trial Update: The Multicentre Selective Lymphadenectomy Trial - 3 [NA]

View source ↗

Summary

The multicentre trial evaluating selective lymphadenectomy for stage III cutaneous melanoma is currently recruiting at multiple centers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous Melanoma

Snippet

Sponsor: Melanoma Institute Australia | Conditions: Cutaneous Melanoma, Stage III | NA | Status: RECRUITING